Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hoskin

Showing results (81-90 of 241) with videos related to

Pageof 25
Sort By:
Brachytherapy|December 23, 2014
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator positionKaren S Nkiwane, Richard Pötter, Lars U Fokdal, et al.
Communications Biology|June 18, 2024
Digital spatial profiling of the microenvironment of muscle invasive bladder cancerMichael Eyers, Joely Irlam, Gayle Marshall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literatureRita Simões, Yolanda Augustin, Sarah Gulliford, et al.
BJU International|September 24, 2013
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UKPeter D Dickinson, Jahangeer Malik, Paula Mandall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2022
Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factorsSri Harsha Kombathula, Anthea Cree, Priya V Joshi, et al.
Physics in Medicine and Biology|December 22, 2022
Feasibility of using a dual isocentre technique for treating cervical cancer on the 1.5 T MR-LinacRobert W Chuter, Frank Brewster, Louise Retout, et al.
Oncotarget|August 26, 2021
Hypofractionation: less is more?Neethu Billy Graham Mariam, Yee Pei Song, Nuradh Joseph, et al.
Leukemia & Lymphoma|October 21, 2003
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphomaAndrew Grigg, Philippe Solal-Celigny, Peter Hoskin, et al.
Pediatric Blood & Cancer|January 19, 2022
Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcomaSara Lobo, Mark N Gaze, Olga Slater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trialLisa Lowry, Paul Smith, Wendi Qian, et al.
Pageof 25

Showing results (81-90 of 241) with videos related to

Sort By:
Pageof 25
Brachytherapy|December 23, 2014
Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator positionKaren S Nkiwane, Richard Pötter, Lars U Fokdal, et al.
Communications Biology|June 18, 2024
Digital spatial profiling of the microenvironment of muscle invasive bladder cancerMichael Eyers, Joely Irlam, Gayle Marshall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2023
Toxicity, normal tissue and dose-volume planning parameters for radiotherapy in soft tissue sarcoma of the extremities: A systematic review of the literatureRita Simões, Yolanda Augustin, Sarah Gulliford, et al.
BJU International|September 24, 2013
Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UKPeter D Dickinson, Jahangeer Malik, Paula Mandall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 14, 2022
Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factorsSri Harsha Kombathula, Anthea Cree, Priya V Joshi, et al.
Physics in Medicine and Biology|December 22, 2022
Feasibility of using a dual isocentre technique for treating cervical cancer on the 1.5 T MR-LinacRobert W Chuter, Frank Brewster, Louise Retout, et al.
Oncotarget|August 26, 2021
Hypofractionation: less is more?Neethu Billy Graham Mariam, Yee Pei Song, Nuradh Joseph, et al.
Leukemia & Lymphoma|October 21, 2003
Open-label, randomized study of pegfilgrastim vs. daily filgrastim as an adjunct to chemotherapy in elderly patients with non-Hodgkin's lymphomaAndrew Grigg, Philippe Solal-Celigny, Peter Hoskin, et al.
Pediatric Blood & Cancer|January 19, 2022
Bladder function after conservative surgery and high-dose rate brachytherapy for bladder-prostate rhabdomyosarcomaSara Lobo, Mark N Gaze, Olga Slater, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2011
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trialLisa Lowry, Paul Smith, Wendi Qian, et al.
Pageof 25